A Phase III, multi-center, open-label study of Solithromycin in patients with otorhinolaryngological infection

Trial Profile

A Phase III, multi-center, open-label study of Solithromycin in patients with otorhinolaryngological infection

Recruiting
Phase of Trial: Phase III

Latest Information Update: 14 Dec 2016

At a glance

  • Drugs Solithromycin (Primary)
  • Indications Otitis media; Otorhinolaryngological infections; Tonsillitis
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Toyama Chemical
  • Most Recent Events

    • 14 Dec 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top